ClariVest Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

ClariVest Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8	Closed	-$1K	–	777
2022 Q2	$1K	Hold	8	–	–	﹤0.01%	683
2022 Q1	$1K	Sell	8 -36,380	-100%	-$3.55M	﹤0.01%	684
2021 Q4	$3.92M	Sell	36,388 -3,600	-9%	-$393K	0.12%	161
2021 Q3	$4.38M	Sell	39,988 -5,100	-11%	-$529K	0.14%	154
2021 Q2	$4.22M	Sell	45,088 -7,698	-15%	-$708K	0.14%	149
2021 Q1	$4.86M	Sell	52,786 -5,361	-9%	-$452K	0.17%	115
2020 Q4	$4.25M	Buy	58,147 +11,400	+24%	+$847K	0.14%	123
2020 Q3	$3.63M	Sell	46,747 -983	-2%	-$67.6K	0.12%	144
2020 Q2	$2.65M	Sell	47,730 -46,892	-50%	-$2.01M	0.07%	190
2020 Q1	$2.8M	Sell	94,622 -54,319	-36%	-$1.84M	0.08%	164
2019 Q4	$5.39M	Sell	148,941 -73,440	-33%	-$2.25M	0.12%	138
2019 Q3	$6.05M	Sell	222,381 -2,800	-1%	-$72.4K	0.14%	148
2019 Q2	$5.42M	Sell	225,181 -1,700	-0.7%	-$43.1K	0.12%	153
2019 Q1	$6M	Buy	226,881 +86,944	+62%	+$2.06M	0.12%	163
2018 Q4	$2.73M	Buy	+139,937	New	+$2.74M	0.06%	253
2014 Q2	–	Sell	-13,259	Closed	-$201K	–	653
2014 Q1	$201K	Sell	13,259 -14,087	-52%	-$159K	0.01%	354
2013 Q4	$208K	Buy	+27,346	New	+$147K	0.01%	352

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

ClariVest Asset Management's HZNP Position: Q3 2022 in Review

ClariVest Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 8 shares — an estimated $1K sold.

ClariVest Asset Management first reported a position in HZNP in Q4 2013 and held it in 17 quarters. The position peaked at $6.05M in Q3 2019. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

ClariVest Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
ClariVest Asset Management sold 8 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $1K.
ClariVest Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 17 quarters.
ClariVest Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $6.05M in Q3 2019.
530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on ClariVest Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.